nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—cardial valve—germ cell cancer	0.0924	0.218	CbGeAlD
Dabigatran etexilate—ABCB1—Dactinomycin—germ cell cancer	0.0636	0.319	CbGbCtD
Dabigatran etexilate—ABCB1—Vinblastine—germ cell cancer	0.0398	0.2	CbGbCtD
Dabigatran etexilate—ABCB1—Cisplatin—germ cell cancer	0.0365	0.183	CbGbCtD
Dabigatran etexilate—ABCB1—Etoposide—germ cell cancer	0.0359	0.18	CbGbCtD
Dabigatran etexilate—ABCB1—Methotrexate—germ cell cancer	0.0237	0.119	CbGbCtD
Dabigatran etexilate—F2—urine—germ cell cancer	0.0199	0.0471	CbGeAlD
Dabigatran etexilate—F2—appendage—germ cell cancer	0.0194	0.0458	CbGeAlD
Dabigatran etexilate—F2—endothelium—germ cell cancer	0.0117	0.0277	CbGeAlD
Dabigatran etexilate—F2—blood vessel—germ cell cancer	0.0108	0.0255	CbGeAlD
Dabigatran etexilate—F2—neck—germ cell cancer	0.00773	0.0183	CbGeAlD
Dabigatran etexilate—CES2—trigeminal ganglion—germ cell cancer	0.00744	0.0176	CbGeAlD
Dabigatran etexilate—CES1—neck—germ cell cancer	0.00709	0.0168	CbGeAlD
Dabigatran etexilate—NQO2—trigeminal ganglion—germ cell cancer	0.00665	0.0157	CbGeAlD
Dabigatran etexilate—CES2—eye—germ cell cancer	0.00641	0.0151	CbGeAlD
Dabigatran etexilate—CES2—retina—germ cell cancer	0.00635	0.015	CbGeAlD
Dabigatran etexilate—UGT2B15—endocrine gland—germ cell cancer	0.00603	0.0143	CbGeAlD
Dabigatran etexilate—NQO2—brainstem—germ cell cancer	0.00588	0.0139	CbGeAlD
Dabigatran etexilate—CES2—telencephalon—germ cell cancer	0.00584	0.0138	CbGeAlD
Dabigatran etexilate—F2—eye—germ cell cancer	0.00575	0.0136	CbGeAlD
Dabigatran etexilate—CES2—skin of body—germ cell cancer	0.00557	0.0132	CbGeAlD
Dabigatran etexilate—CES2—decidua—germ cell cancer	0.00554	0.0131	CbGeAlD
Dabigatran etexilate—NQO2—telencephalon—germ cell cancer	0.00522	0.0123	CbGeAlD
Dabigatran etexilate—NQO2—decidua—germ cell cancer	0.00495	0.0117	CbGeAlD
Dabigatran etexilate—CES2—gonad—germ cell cancer	0.00487	0.0115	CbGeAlD
Dabigatran etexilate—CES2—uterus—germ cell cancer	0.00484	0.0114	CbGeAlD
Dabigatran etexilate—CES2—pituitary gland—germ cell cancer	0.00476	0.0112	CbGeAlD
Dabigatran etexilate—CES2—medulla oblongata—germ cell cancer	0.00459	0.0108	CbGeAlD
Dabigatran etexilate—UGT1A9—endocrine gland—germ cell cancer	0.00457	0.0108	CbGeAlD
Dabigatran etexilate—NQO2—uterus—germ cell cancer	0.00433	0.0102	CbGeAlD
Dabigatran etexilate—NQO2—pituitary gland—germ cell cancer	0.00425	0.01	CbGeAlD
Dabigatran etexilate—CES2—adrenal gland—germ cell cancer	0.00425	0.01	CbGeAlD
Dabigatran etexilate—CES2—midbrain—germ cell cancer	0.00419	0.00991	CbGeAlD
Dabigatran etexilate—CES2—bone marrow—germ cell cancer	0.00411	0.00971	CbGeAlD
Dabigatran etexilate—NQO2—medulla oblongata—germ cell cancer	0.0041	0.00969	CbGeAlD
Dabigatran etexilate—CES2—spinal cord—germ cell cancer	0.00409	0.00967	CbGeAlD
Dabigatran etexilate—CES2—female gonad—germ cell cancer	0.00396	0.00936	CbGeAlD
Dabigatran etexilate—F2—adrenal gland—germ cell cancer	0.00381	0.009	CbGeAlD
Dabigatran etexilate—NQO2—adrenal gland—germ cell cancer	0.0038	0.00897	CbGeAlD
Dabigatran etexilate—NQO2—midbrain—germ cell cancer	0.00375	0.00886	CbGeAlD
Dabigatran etexilate—F2—bone marrow—germ cell cancer	0.00369	0.00871	CbGeAlD
Dabigatran etexilate—CES2—endocrine gland—germ cell cancer	0.00368	0.00871	CbGeAlD
Dabigatran etexilate—UGT2B7—endocrine gland—germ cell cancer	0.00368	0.00871	CbGeAlD
Dabigatran etexilate—NQO2—bone marrow—germ cell cancer	0.00367	0.00868	CbGeAlD
Dabigatran etexilate—F2—spinal cord—germ cell cancer	0.00367	0.00867	CbGeAlD
Dabigatran etexilate—NQO2—spinal cord—germ cell cancer	0.00366	0.00864	CbGeAlD
Dabigatran etexilate—CES2—head—germ cell cancer	0.00364	0.00859	CbGeAlD
Dabigatran etexilate—Oesophagitis—Dactinomycin—germ cell cancer	0.0036	0.00953	CcSEcCtD
Dabigatran etexilate—F2—female gonad—germ cell cancer	0.00355	0.0084	CbGeAlD
Dabigatran etexilate—NQO2—female gonad—germ cell cancer	0.00354	0.00836	CbGeAlD
Dabigatran etexilate—CES2—testis—germ cell cancer	0.00351	0.0083	CbGeAlD
Dabigatran etexilate—UGT2B7—testis—germ cell cancer	0.00351	0.0083	CbGeAlD
Dabigatran etexilate—CES1—adrenal gland—germ cell cancer	0.0035	0.00827	CbGeAlD
Dabigatran etexilate—F2—endocrine gland—germ cell cancer	0.0033	0.00781	CbGeAlD
Dabigatran etexilate—NQO2—endocrine gland—germ cell cancer	0.00329	0.00778	CbGeAlD
Dabigatran etexilate—F2—head—germ cell cancer	0.00326	0.00771	CbGeAlD
Dabigatran etexilate—CES1—female gonad—germ cell cancer	0.00326	0.00771	CbGeAlD
Dabigatran etexilate—NQO2—head—germ cell cancer	0.00325	0.00768	CbGeAlD
Dabigatran etexilate—CES2—cerebellum—germ cell cancer	0.00324	0.00767	CbGeAlD
Dabigatran etexilate—Chest discomfort—Etoposide—germ cell cancer	0.00322	0.00854	CcSEcCtD
Dabigatran etexilate—NQO2—testis—germ cell cancer	0.00314	0.00742	CbGeAlD
Dabigatran etexilate—Angina pectoris—Vinblastine—germ cell cancer	0.00305	0.0081	CcSEcCtD
Dabigatran etexilate—CES1—endocrine gland—germ cell cancer	0.00303	0.00717	CbGeAlD
Dabigatran etexilate—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.003	0.00794	CcSEcCtD
Dabigatran etexilate—CES1—head—germ cell cancer	0.003	0.00708	CbGeAlD
Dabigatran etexilate—NQO2—cerebellum—germ cell cancer	0.0029	0.00685	CbGeAlD
Dabigatran etexilate—CES1—testis—germ cell cancer	0.00289	0.00684	CbGeAlD
Dabigatran etexilate—Acute coronary syndrome—Vinblastine—germ cell cancer	0.00276	0.00731	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Vinblastine—germ cell cancer	0.00274	0.00726	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Ifosfamide—germ cell cancer	0.00268	0.00711	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Dactinomycin—germ cell cancer	0.00264	0.00699	CcSEcCtD
Dabigatran etexilate—CES2—brain—germ cell cancer	0.00264	0.00623	CbGeAlD
Dabigatran etexilate—Gastrointestinal haemorrhage—Ifosfamide—germ cell cancer	0.00262	0.00694	CcSEcCtD
Dabigatran etexilate—Pain in extremity—Ifosfamide—germ cell cancer	0.00262	0.00694	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Ifosfamide—germ cell cancer	0.00262	0.00694	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Bleomycin—germ cell cancer	0.00261	0.0069	CcSEcCtD
Dabigatran etexilate—Oesophagitis—Etoposide—germ cell cancer	0.0026	0.0069	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00257	0.00682	CcSEcCtD
Dabigatran etexilate—CES2—lymph node—germ cell cancer	0.00255	0.00602	CbGeAlD
Dabigatran etexilate—Haemoglobin—Vinblastine—germ cell cancer	0.00252	0.00669	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Vinblastine—germ cell cancer	0.00251	0.00665	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Cisplatin—germ cell cancer	0.00249	0.0066	CcSEcCtD
Dabigatran etexilate—Dysphagia—Dactinomycin—germ cell cancer	0.00247	0.00655	CcSEcCtD
Dabigatran etexilate—Pneumonia—Bleomycin—germ cell cancer	0.00238	0.0063	CcSEcCtD
Dabigatran etexilate—F2—brain—germ cell cancer	0.00236	0.00559	CbGeAlD
Dabigatran etexilate—NQO2—brain—germ cell cancer	0.00236	0.00557	CbGeAlD
Dabigatran etexilate—Acute coronary syndrome—Bleomycin—germ cell cancer	0.00233	0.00617	CcSEcCtD
Dabigatran etexilate—ABCB1—blood vessel—germ cell cancer	0.00232	0.00549	CbGeAlD
Dabigatran etexilate—Myocardial infarction—Bleomycin—germ cell cancer	0.00231	0.00613	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Etoposide—germ cell cancer	0.00228	0.00604	CcSEcCtD
Dabigatran etexilate—NQO2—lymph node—germ cell cancer	0.00228	0.00538	CbGeAlD
Dabigatran etexilate—Gastrointestinal haemorrhage—Cisplatin—germ cell cancer	0.00226	0.00598	CcSEcCtD
Dabigatran etexilate—Haematuria—Bleomycin—germ cell cancer	0.00225	0.00597	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Ifosfamide—germ cell cancer	0.00223	0.0059	CcSEcCtD
Dabigatran etexilate—Pneumonia—Dactinomycin—germ cell cancer	0.00222	0.00587	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Ifosfamide—germ cell cancer	0.0022	0.00584	CcSEcCtD
Dabigatran etexilate—CES1—brain—germ cell cancer	0.00217	0.00513	CbGeAlD
Dabigatran etexilate—Haemoglobin—Bleomycin—germ cell cancer	0.00213	0.00565	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Bleomycin—germ cell cancer	0.00212	0.00562	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Etoposide—germ cell cancer	0.00212	0.00562	CcSEcCtD
Dabigatran etexilate—CES1—lymph node—germ cell cancer	0.0021	0.00496	CbGeAlD
Dabigatran etexilate—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00203	0.00539	CcSEcCtD
Dabigatran etexilate—Pneumonia—Ifosfamide—germ cell cancer	0.00203	0.00538	CcSEcCtD
Dabigatran etexilate—Anaemia—Vinblastine—germ cell cancer	0.00202	0.00535	CcSEcCtD
Dabigatran etexilate—Nasopharyngitis—Cisplatin—germ cell cancer	0.00202	0.00535	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Ifosfamide—germ cell cancer	0.00202	0.00535	CcSEcCtD
Dabigatran etexilate—Infestation—Ifosfamide—germ cell cancer	0.00202	0.00535	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00199	0.00527	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Ifosfamide—germ cell cancer	0.00198	0.00524	CcSEcCtD
Dabigatran etexilate—Haematuria—Ifosfamide—germ cell cancer	0.00192	0.0051	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00191	0.00506	CcSEcCtD
Dabigatran etexilate—Bone disorder—Methotrexate—germ cell cancer	0.00189	0.00501	CcSEcCtD
Dabigatran etexilate—Hypertension—Vinblastine—germ cell cancer	0.00189	0.005	CcSEcCtD
Dabigatran etexilate—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.00188	0.00497	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Cisplatin—germ cell cancer	0.00187	0.00496	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.00182	0.00484	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Ifosfamide—germ cell cancer	0.00182	0.00483	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Ifosfamide—germ cell cancer	0.00181	0.0048	CcSEcCtD
Dabigatran etexilate—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.0018	0.00478	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00179	0.00474	CcSEcCtD
Dabigatran etexilate—Dysphagia—Etoposide—germ cell cancer	0.00179	0.00474	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00178	0.00472	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Ifosfamide—germ cell cancer	0.00178	0.00471	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Etoposide—germ cell cancer	0.00176	0.00466	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Vinblastine—germ cell cancer	0.00175	0.00463	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00172	0.00455	CcSEcCtD
Dabigatran etexilate—Anaemia—Bleomycin—germ cell cancer	0.00171	0.00452	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Cisplatin—germ cell cancer	0.00171	0.00452	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Ifosfamide—germ cell cancer	0.00168	0.00446	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00165	0.00436	CcSEcCtD
Dabigatran etexilate—Angiopathy—Ifosfamide—germ cell cancer	0.00164	0.00436	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Ifosfamide—germ cell cancer	0.00164	0.00434	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00163	0.00433	CcSEcCtD
Dabigatran etexilate—Cough—Bleomycin—germ cell cancer	0.00161	0.00427	CcSEcCtD
Dabigatran etexilate—Pneumonia—Etoposide—germ cell cancer	0.0016	0.00425	CcSEcCtD
Dabigatran etexilate—Infestation—Etoposide—germ cell cancer	0.00159	0.00422	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Etoposide—germ cell cancer	0.00159	0.00422	CcSEcCtD
Dabigatran etexilate—Anaemia—Dactinomycin—germ cell cancer	0.00159	0.00422	CcSEcCtD
Dabigatran etexilate—Malnutrition—Ifosfamide—germ cell cancer	0.00158	0.00418	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Etoposide—germ cell cancer	0.00157	0.00416	CcSEcCtD
Dabigatran etexilate—Chest pain—Bleomycin—germ cell cancer	0.00157	0.00416	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Etoposide—germ cell cancer	0.00156	0.00414	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Methotrexate—germ cell cancer	0.00154	0.00409	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Cisplatin—germ cell cancer	0.00154	0.00409	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Cisplatin—germ cell cancer	0.00153	0.00407	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Cisplatin—germ cell cancer	0.00153	0.00406	CcSEcCtD
Dabigatran etexilate—Constipation—Vinblastine—germ cell cancer	0.00152	0.00404	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Etoposide—germ cell cancer	0.00151	0.004	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Bleomycin—germ cell cancer	0.00151	0.00399	CcSEcCtD
Dabigatran etexilate—Infection—Bleomycin—germ cell cancer	0.0015	0.00397	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Bleomycin—germ cell cancer	0.00147	0.00391	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00146	0.00386	CcSEcCtD
Dabigatran etexilate—Anaemia—Ifosfamide—germ cell cancer	0.00146	0.00386	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Cisplatin—germ cell cancer	0.00145	0.00384	CcSEcCtD
Dabigatran etexilate—Angioedema—Ifosfamide—germ cell cancer	0.00144	0.00382	CcSEcCtD
Dabigatran etexilate—ABCB1—trigeminal ganglion—germ cell cancer	0.00143	0.00339	CbGeAlD
Dabigatran etexilate—Urinary tract disorder—Etoposide—germ cell cancer	0.00141	0.00375	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Cisplatin—germ cell cancer	0.00141	0.00374	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Vinblastine—germ cell cancer	0.00141	0.00374	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Cisplatin—germ cell cancer	0.00141	0.00373	CcSEcCtD
Dabigatran etexilate—Hypotension—Bleomycin—germ cell cancer	0.00141	0.00373	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Etoposide—germ cell cancer	0.0014	0.00372	CcSEcCtD
Dabigatran etexilate—Infection—Dactinomycin—germ cell cancer	0.0014	0.0037	CcSEcCtD
Dabigatran etexilate—Palpitations—Ifosfamide—germ cell cancer	0.00139	0.00369	CcSEcCtD
Dabigatran etexilate—ABCB1—embryo—germ cell cancer	0.00139	0.00327	CbGeAlD
Dabigatran etexilate—Cough—Ifosfamide—germ cell cancer	0.00138	0.00365	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00138	0.00365	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00137	0.00364	CcSEcCtD
Dabigatran etexilate—Hypertension—Ifosfamide—germ cell cancer	0.00136	0.00361	CcSEcCtD
Dabigatran etexilate—Malnutrition—Cisplatin—germ cell cancer	0.00136	0.0036	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Bleomycin—germ cell cancer	0.00134	0.00356	CcSEcCtD
Dabigatran etexilate—Arthralgia—Ifosfamide—germ cell cancer	0.00134	0.00356	CcSEcCtD
Dabigatran etexilate—Chest pain—Ifosfamide—germ cell cancer	0.00134	0.00356	CcSEcCtD
Dabigatran etexilate—Flatulence—Cisplatin—germ cell cancer	0.00134	0.00355	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00133	0.00353	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Etoposide—germ cell cancer	0.00133	0.00352	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Vinblastine—germ cell cancer	0.00131	0.00348	CcSEcCtD
Dabigatran etexilate—Angiopathy—Etoposide—germ cell cancer	0.0013	0.00344	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Etoposide—germ cell cancer	0.00129	0.00343	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Etoposide—germ cell cancer	0.00129	0.00342	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00129	0.00341	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00128	0.00339	CcSEcCtD
Dabigatran etexilate—Asthenia—Vinblastine—germ cell cancer	0.00128	0.00339	CcSEcCtD
Dabigatran etexilate—Infection—Ifosfamide—germ cell cancer	0.00128	0.00339	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Ifosfamide—germ cell cancer	0.00126	0.00335	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00126	0.00334	CcSEcCtD
Dabigatran etexilate—Anaemia—Cisplatin—germ cell cancer	0.00126	0.00333	CcSEcCtD
Dabigatran etexilate—Skin disorder—Ifosfamide—germ cell cancer	0.00125	0.00331	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Methotrexate—germ cell cancer	0.00124	0.00328	CcSEcCtD
Dabigatran etexilate—ABCB1—retina—germ cell cancer	0.00122	0.00289	CbGeAlD
Dabigatran etexilate—Diarrhoea—Vinblastine—germ cell cancer	0.00122	0.00323	CcSEcCtD
Dabigatran etexilate—Fatigue—Dactinomycin—germ cell cancer	0.00121	0.00321	CcSEcCtD
Dabigatran etexilate—Back pain—Etoposide—germ cell cancer	0.0012	0.00319	CcSEcCtD
Dabigatran etexilate—Hypotension—Ifosfamide—germ cell cancer	0.0012	0.00319	CcSEcCtD
Dabigatran etexilate—Urticaria—Bleomycin—germ cell cancer	0.0012	0.00317	CcSEcCtD
Dabigatran etexilate—Dizziness—Vinblastine—germ cell cancer	0.00118	0.00313	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00117	0.00311	CcSEcCtD
Dabigatran etexilate—Anaemia—Etoposide—germ cell cancer	0.00115	0.00305	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00115	0.00305	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00115	0.00304	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Ifosfamide—germ cell cancer	0.00115	0.00304	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Methotrexate—germ cell cancer	0.00114	0.00303	CcSEcCtD
Dabigatran etexilate—Vomiting—Vinblastine—germ cell cancer	0.00113	0.00301	CcSEcCtD
Dabigatran etexilate—ABCB1—telencephalon—germ cell cancer	0.00113	0.00266	CbGeAlD
Dabigatran etexilate—Headache—Vinblastine—germ cell cancer	0.00112	0.00296	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00111	0.00295	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dactinomycin—germ cell cancer	0.00111	0.00294	CcSEcCtD
Dabigatran etexilate—Fatigue—Ifosfamide—germ cell cancer	0.00111	0.00294	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Cisplatin—germ cell cancer	0.00111	0.00294	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Bleomycin—germ cell cancer	0.00111	0.00294	CcSEcCtD
Dabigatran etexilate—Infection—Cisplatin—germ cell cancer	0.0011	0.00292	CcSEcCtD
Dabigatran etexilate—Constipation—Ifosfamide—germ cell cancer	0.0011	0.00292	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Etoposide—germ cell cancer	0.00109	0.0029	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Cisplatin—germ cell cancer	0.00109	0.00288	CcSEcCtD
Dabigatran etexilate—Cough—Etoposide—germ cell cancer	0.00109	0.00288	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Cisplatin—germ cell cancer	0.00109	0.00288	CcSEcCtD
Dabigatran etexilate—Asthenia—Bleomycin—germ cell cancer	0.00108	0.00286	CcSEcCtD
Dabigatran etexilate—Skin disorder—Cisplatin—germ cell cancer	0.00108	0.00286	CcSEcCtD
Dabigatran etexilate—Hypertension—Etoposide—germ cell cancer	0.00108	0.00285	CcSEcCtD
Dabigatran etexilate—ABCB1—decidua—germ cell cancer	0.00107	0.00252	CbGeAlD
Dabigatran etexilate—Pruritus—Bleomycin—germ cell cancer	0.00107	0.00282	CcSEcCtD
Dabigatran etexilate—Chest pain—Etoposide—germ cell cancer	0.00106	0.00281	CcSEcCtD
Dabigatran etexilate—Nausea—Vinblastine—germ cell cancer	0.00106	0.00281	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00105	0.00279	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00105	0.00279	CcSEcCtD
Dabigatran etexilate—Hypotension—Cisplatin—germ cell cancer	0.00104	0.00275	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Dactinomycin—germ cell cancer	0.00103	0.00274	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Methotrexate—germ cell cancer	0.00103	0.00272	CcSEcCtD
Dabigatran etexilate—Urticaria—Ifosfamide—germ cell cancer	0.00102	0.00271	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Ifosfamide—germ cell cancer	0.00102	0.0027	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Etoposide—germ cell cancer	0.00102	0.00269	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00101	0.00268	CcSEcCtD
Dabigatran etexilate—Infection—Etoposide—germ cell cancer	0.00101	0.00268	CcSEcCtD
Dabigatran etexilate—Asthenia—Dactinomycin—germ cell cancer	0.00101	0.00267	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Etoposide—germ cell cancer	0.000995	0.00264	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000995	0.00264	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Cisplatin—germ cell cancer	0.000989	0.00262	CcSEcCtD
Dabigatran etexilate—Skin disorder—Etoposide—germ cell cancer	0.000988	0.00262	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Dactinomycin—germ cell cancer	0.000961	0.00255	CcSEcCtD
Dabigatran etexilate—Pneumonia—Methotrexate—germ cell cancer	0.00096	0.00255	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000958	0.00254	CcSEcCtD
Dabigatran etexilate—Vomiting—Bleomycin—germ cell cancer	0.000958	0.00254	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Methotrexate—germ cell cancer	0.000955	0.00253	CcSEcCtD
Dabigatran etexilate—Infestation—Methotrexate—germ cell cancer	0.000955	0.00253	CcSEcCtD
Dabigatran etexilate—Hypotension—Etoposide—germ cell cancer	0.00095	0.00252	CcSEcCtD
Dabigatran etexilate—Rash—Bleomycin—germ cell cancer	0.00095	0.00252	CcSEcCtD
Dabigatran etexilate—Dermatitis—Bleomycin—germ cell cancer	0.000949	0.00251	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Ifosfamide—germ cell cancer	0.000948	0.00251	CcSEcCtD
Dabigatran etexilate—ABCB1—gonad—germ cell cancer	0.00094	0.00222	CbGeAlD
Dabigatran etexilate—ABCB1—uterus—germ cell cancer	0.000934	0.00221	CbGeAlD
Dabigatran etexilate—Asthenia—Ifosfamide—germ cell cancer	0.000924	0.00245	CcSEcCtD
Dabigatran etexilate—ABCB1—pituitary gland—germ cell cancer	0.000917	0.00217	CbGeAlD
Dabigatran etexilate—Pruritus—Ifosfamide—germ cell cancer	0.000911	0.00241	CcSEcCtD
Dabigatran etexilate—Haematuria—Methotrexate—germ cell cancer	0.00091	0.00241	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Etoposide—germ cell cancer	0.000906	0.0024	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000903	0.00239	CcSEcCtD
Dabigatran etexilate—Epistaxis—Methotrexate—germ cell cancer	0.000901	0.00239	CcSEcCtD
Dabigatran etexilate—Nausea—Bleomycin—germ cell cancer	0.000895	0.00237	CcSEcCtD
Dabigatran etexilate—Vomiting—Dactinomycin—germ cell cancer	0.000893	0.00237	CcSEcCtD
Dabigatran etexilate—Rash—Dactinomycin—germ cell cancer	0.000886	0.00235	CcSEcCtD
Dabigatran etexilate—ABCB1—medulla oblongata—germ cell cancer	0.000885	0.00209	CbGeAlD
Dabigatran etexilate—Diarrhoea—Ifosfamide—germ cell cancer	0.000881	0.00233	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000878	0.00233	CcSEcCtD
Dabigatran etexilate—Fatigue—Etoposide—germ cell cancer	0.000877	0.00232	CcSEcCtD
Dabigatran etexilate—Constipation—Etoposide—germ cell cancer	0.000869	0.0023	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methotrexate—germ cell cancer	0.000861	0.00228	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methotrexate—germ cell cancer	0.000857	0.00227	CcSEcCtD
Dabigatran etexilate—Dizziness—Ifosfamide—germ cell cancer	0.000851	0.00226	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Methotrexate—germ cell cancer	0.000846	0.00224	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Methotrexate—germ cell cancer	0.00084	0.00223	CcSEcCtD
Dabigatran etexilate—Nausea—Dactinomycin—germ cell cancer	0.000834	0.00221	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Etoposide—germ cell cancer	0.000831	0.0022	CcSEcCtD
Dabigatran etexilate—ABCB1—adrenal gland—germ cell cancer	0.000819	0.00194	CbGeAlD
Dabigatran etexilate—Vomiting—Ifosfamide—germ cell cancer	0.000818	0.00217	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Cisplatin—germ cell cancer	0.000818	0.00217	CcSEcCtD
Dabigatran etexilate—Rash—Ifosfamide—germ cell cancer	0.000812	0.00215	CcSEcCtD
Dabigatran etexilate—Dermatitis—Ifosfamide—germ cell cancer	0.000811	0.00215	CcSEcCtD
Dabigatran etexilate—ABCB1—midbrain—germ cell cancer	0.000809	0.00191	CbGeAlD
Dabigatran etexilate—Urticaria—Etoposide—germ cell cancer	0.000808	0.00214	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Etoposide—germ cell cancer	0.000804	0.00213	CcSEcCtD
Dabigatran etexilate—Asthenia—Cisplatin—germ cell cancer	0.000796	0.00211	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methotrexate—germ cell cancer	0.000795	0.00211	CcSEcCtD
Dabigatran etexilate—ABCB1—bone marrow—germ cell cancer	0.000793	0.00187	CbGeAlD
Dabigatran etexilate—ABCB1—spinal cord—germ cell cancer	0.000789	0.00187	CbGeAlD
Dabigatran etexilate—Angiopathy—Methotrexate—germ cell cancer	0.000778	0.00206	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methotrexate—germ cell cancer	0.000774	0.00205	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methotrexate—germ cell cancer	0.000772	0.00205	CcSEcCtD
Dabigatran etexilate—Nausea—Ifosfamide—germ cell cancer	0.000765	0.00203	CcSEcCtD
Dabigatran etexilate—ABCB1—female gonad—germ cell cancer	0.000764	0.00181	CbGeAlD
Dabigatran etexilate—Diarrhoea—Cisplatin—germ cell cancer	0.000759	0.00201	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Etoposide—germ cell cancer	0.000749	0.00199	CcSEcCtD
Dabigatran etexilate—Malnutrition—Methotrexate—germ cell cancer	0.000746	0.00198	CcSEcCtD
Dabigatran etexilate—Asthenia—Etoposide—germ cell cancer	0.000729	0.00193	CcSEcCtD
Dabigatran etexilate—Back pain—Methotrexate—germ cell cancer	0.000722	0.00191	CcSEcCtD
Dabigatran etexilate—Pruritus—Etoposide—germ cell cancer	0.000719	0.00191	CcSEcCtD
Dabigatran etexilate—ABCB1—endocrine gland—germ cell cancer	0.000711	0.00168	CbGeAlD
Dabigatran etexilate—Vomiting—Cisplatin—germ cell cancer	0.000706	0.00187	CcSEcCtD
Dabigatran etexilate—ABCB1—head—germ cell cancer	0.000702	0.00166	CbGeAlD
Dabigatran etexilate—Rash—Cisplatin—germ cell cancer	0.0007	0.00185	CcSEcCtD
Dabigatran etexilate—Dermatitis—Cisplatin—germ cell cancer	0.000699	0.00185	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Etoposide—germ cell cancer	0.000696	0.00184	CcSEcCtD
Dabigatran etexilate—Anaemia—Methotrexate—germ cell cancer	0.00069	0.00183	CcSEcCtD
Dabigatran etexilate—ABCB1—testis—germ cell cancer	0.000678	0.0016	CbGeAlD
Dabigatran etexilate—Dizziness—Etoposide—germ cell cancer	0.000672	0.00178	CcSEcCtD
Dabigatran etexilate—Nausea—Cisplatin—germ cell cancer	0.000659	0.00175	CcSEcCtD
Dabigatran etexilate—Cough—Methotrexate—germ cell cancer	0.000651	0.00173	CcSEcCtD
Dabigatran etexilate—Vomiting—Etoposide—germ cell cancer	0.000646	0.00171	CcSEcCtD
Dabigatran etexilate—Rash—Etoposide—germ cell cancer	0.000641	0.0017	CcSEcCtD
Dabigatran etexilate—Dermatitis—Etoposide—germ cell cancer	0.00064	0.0017	CcSEcCtD
Dabigatran etexilate—Headache—Etoposide—germ cell cancer	0.000637	0.00169	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methotrexate—germ cell cancer	0.000635	0.00168	CcSEcCtD
Dabigatran etexilate—Chest pain—Methotrexate—germ cell cancer	0.000635	0.00168	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000631	0.00167	CcSEcCtD
Dabigatran etexilate—ABCB1—cerebellum—germ cell cancer	0.000626	0.00148	CbGeAlD
Dabigatran etexilate—Anaphylactic shock—Methotrexate—germ cell cancer	0.000609	0.00161	CcSEcCtD
Dabigatran etexilate—Infection—Methotrexate—germ cell cancer	0.000605	0.0016	CcSEcCtD
Dabigatran etexilate—Nausea—Etoposide—germ cell cancer	0.000604	0.0016	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methotrexate—germ cell cancer	0.000597	0.00158	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Methotrexate—germ cell cancer	0.000596	0.00158	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methotrexate—germ cell cancer	0.000592	0.00157	CcSEcCtD
Dabigatran etexilate—Hypotension—Methotrexate—germ cell cancer	0.000569	0.00151	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000555	0.00147	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Methotrexate—germ cell cancer	0.000543	0.00144	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methotrexate—germ cell cancer	0.000536	0.00142	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000526	0.00139	CcSEcCtD
Dabigatran etexilate—Fatigue—Methotrexate—germ cell cancer	0.000525	0.00139	CcSEcCtD
Dabigatran etexilate—ABCB1—brain—germ cell cancer	0.000508	0.0012	CbGeAlD
Dabigatran etexilate—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000498	0.00132	CcSEcCtD
Dabigatran etexilate—ABCB1—lymph node—germ cell cancer	0.000491	0.00116	CbGeAlD
Dabigatran etexilate—Urticaria—Methotrexate—germ cell cancer	0.000484	0.00128	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methotrexate—germ cell cancer	0.000481	0.00128	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methotrexate—germ cell cancer	0.000449	0.00119	CcSEcCtD
Dabigatran etexilate—Asthenia—Methotrexate—germ cell cancer	0.000437	0.00116	CcSEcCtD
Dabigatran etexilate—Pruritus—Methotrexate—germ cell cancer	0.000431	0.00114	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methotrexate—germ cell cancer	0.000417	0.0011	CcSEcCtD
Dabigatran etexilate—Dizziness—Methotrexate—germ cell cancer	0.000403	0.00107	CcSEcCtD
Dabigatran etexilate—Vomiting—Methotrexate—germ cell cancer	0.000387	0.00103	CcSEcCtD
Dabigatran etexilate—Rash—Methotrexate—germ cell cancer	0.000384	0.00102	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methotrexate—germ cell cancer	0.000384	0.00102	CcSEcCtD
Dabigatran etexilate—Headache—Methotrexate—germ cell cancer	0.000381	0.00101	CcSEcCtD
Dabigatran etexilate—Nausea—Methotrexate—germ cell cancer	0.000362	0.000959	CcSEcCtD
